• Skip to main content

Mushroom Health Benefits

Evidence-based guides to mushroom health benefits.

  • Home
  • Encyclopedia
  • Evidence Grading
  • Safety
  • Editorial Standards
  • About
  • Contact

Adaptogenic Mushrooms and Stress: What the Research Actually Shows

posted on September 1, 2026

“Adaptogen” is not a medical diagnosis category or an FDA drug classification. It is a term from herbal pharmacology used to describe substances that are traditionally thought to help the body handle physical or mental stress without a specific, single-target effect. A small number of human trials on reishi mushroom and multi-mushroom blends have measured stress-related outcomes like cortisol and perceived stress scores, and some show encouraging early results. But the research base is thin: most studies are small, several are funded by the companies selling the tested product, and no major health authority currently rates the evidence as strong. That gap between marketing language and research reality is the most important thing to understand before choosing a mushroom product for stress.

Before you consider a mushroom supplement: interaction risks to know first

Medicinal mushrooms are not automatically safe just because they are natural. Reishi (Ganoderma lucidum), the species most studied for stress, has documented interaction risks that matter more than any potential stress benefit for some people:

  • Blood thinners: Reishi can increase bleeding risk and should be discussed with a healthcare provider before combining with warfarin or other anticoagulant or antiplatelet medications, according to Memorial Sloan Kettering Cancer Center’s integrative medicine service.
  • Immune-suppressing medications: Reishi may stimulate immune activity, which could work against drugs meant to suppress the immune system, such as those used after organ transplants or for autoimmune conditions.
  • Blood pressure medication and upcoming surgery: Because reishi may affect blood pressure and clotting, it is generally not recommended in the weeks before a scheduled surgery.
  • Liver health: Rare but serious cases of liver injury, including fatal outcomes, have been reported in connection with reishi supplement use, particularly with long-term or high-dose use.

Anyone taking prescription medication, managing a chronic illness, or scheduled for surgery should talk with a doctor or pharmacist before adding any mushroom supplement, including ones marketed as adaptogens.

Why the word “adaptogen” doesn’t have one fixed meaning

The National Center for Complementary and Integrative Health (NCCIH), the federal government’s lead research agency for herbal and complementary therapies, does not use or formally define the term “adaptogen” on its herb-specific evidence pages. That absence matters. It means “adaptogen” is a working concept used within herbal medicine and some supplement research, not a regulatory or diagnostic category that comes with agreed testing standards.

In practice, researchers who study adaptogens generally describe them as substances proposed to help the body resist stress broadly rather than treat one specific symptom, and to have a low risk of toxicity at normal doses. Because there is no single certifying body that confirms a plant or fungus meets that description, different manufacturers, herbalists and researchers apply the label somewhat differently. That is why two products can both be marketed as “adaptogenic mushrooms” while resting on very different amounts and types of evidence.

What human research actually exists, by mushroom species

Human clinical evidence on mushrooms and stress specifically is limited compared to the amount of marketing built around it. Here is what has been studied, organized by species and evidence type.

  • Reishi (Ganoderma lucidum), alone: A 2024 randomized study of female college students in India tested reishi supplementation against psychological stress and fitness markers. It is one of the few controlled human trials to isolate reishi’s effect on stress rather than immune or cardiovascular markers, but it involved a single, small, geographically limited population and has not been independently replicated.
  • Reishi combined with ashwagandha: A randomized, double-blind, placebo-controlled trial published in 2025 tested a combined reishi-and-ashwagandha supplement against perceived stress in healthy adults. Because the product combined two ingredients, this study cannot tell you how much of any effect came from reishi specifically versus ashwagandha, which has separately shown some evidence for stress and sleep in NCCIH’s own review.
  • A five-mushroom blend (reishi, lion’s mane, cordyceps, shiitake, maitake): A 12-week randomized, double-blind, placebo-controlled trial in 50 adults with moderate to severe anxiety and stress measured cortisol, ACTH, anxiety scale scores and perceived stress scale scores. The supplement group showed larger reductions than placebo across these markers. This is a genuine controlled trial with objective hormone measurements, which is a strength. It is also small, single-site, described by its own authors as the first study of this exact blend, and funded by the company that manufactures the tested product — all reasons to treat the results as an early signal rather than confirmed proof.
  • Lion’s mane and cordyceps, individually: Human research on these two species has mostly focused on cognition and fatigue-related outcomes rather than stress or anxiety directly. Their presence in mushroom blends marketed for stress relies partly on their role in combination products rather than dedicated single-species stress trials.

A broader 2025 systematic review of adaptogens and stress-related outcomes in humans found that the strongest, most consistent evidence for reducing stress biomarkers and self-reported stress came from plant adaptogens, particularly ashwagandha, not from mushroom species. That review did not include any mushroom-specific trials in its main analysis, which reflects how much smaller the mushroom evidence base still is compared to certain herbs.

Evidence quality at a glance

  • Reishi and general health outcomes (not stress-specific): A 2025 GRADE-based systematic review covering 17 randomized trials and 971 participants rated the overall certainty of evidence as very low, meaning future research is likely to change these conclusions. Full details are in this site’s reishi mushroom research profile.
  • Reishi and psychological stress, single-species: One small randomized trial exists; it has not yet been independently replicated.
  • Five-mushroom blend and anxiety or stress hormones: One small, industry-funded randomized controlled trial with objective biomarkers; described by its own authors as the first of its kind.
  • Plant adaptogens (ashwagandha, rhodiola and others) and stress: A larger, more consistent body of human evidence exists, according to a 2025 systematic review, though the same review notes small sample sizes and inconsistent dosing remain common limitations across this research area too.

Across every category above, the pattern is the same: preliminary human signals exist, but nothing rises to the level of strong, independently confirmed evidence. Readers who want to understand how researchers grade study quality can review this site’s guide to the evidence hierarchy from lab studies to human trials.

Preclinical findings: interesting, but not proof of a stress effect

Much of what gets cited to support mushroom stress claims comes from laboratory or animal research on individual compounds, particularly reishi’s triterpenes and ganoderic acids. These studies have linked certain compounds to anti-inflammatory and antioxidant activity in cells or animal models. That kind of mechanistic research helps explain why scientists are interested in these compounds, but it does not confirm that taking a reishi supplement will lower a person’s stress level or anxiety. Animal and cell-based results frequently fail to hold up once tested in randomized human trials, so they should be read as a reason for further research, not as evidence a product works. More on this distinction, including how extraction method affects which compounds end up in a product, is covered in this site’s article on reishi’s bioactive compounds.

Who should be extra cautious

  • People taking blood thinners, blood pressure medication, or immunosuppressant drugs
  • Anyone scheduled for surgery in the coming weeks
  • People with existing liver disease or a history of liver problems
  • Pregnant or breastfeeding people, since mushroom supplements are not well studied in these groups
  • Anyone currently in cancer treatment, since some mushroom compounds can interfere with tumor marker testing or antioxidant-dependent chemotherapy agents

These are reasons to have a conversation with a healthcare provider before use, not reasons for panic. The point is that “natural” does not mean “risk-free,” especially when a supplement is combined with existing medications.

How to read a mushroom stress study before trusting it

When you come across a headline claiming a mushroom “reduces stress,” it helps to ask a few questions: How many people were in the study? Was it placebo-controlled and blinded? Who funded it? Was the mushroom tested alone or as part of a blend? And has anyone independently repeated the results? Right now, most mushroom-and-stress research answers at least one of those questions in a way that calls for caution — usually small sample size, single-study status, or funding from the company selling the product. This site’s consumer guide to reading a mushroom clinical trial walks through these questions in more detail.

Frequently asked questions

Is reishi mushroom a proven treatment for anxiety or stress?

No. Reishi has been studied in a small number of human trials that measured stress-related outcomes, and some found positive changes compared to placebo. That is different from being a proven treatment. No major health authority currently classifies reishi as an evidence-based treatment for anxiety or stress disorders.

Is “adaptogenic mushroom” a scientific or medical term?

It is a term used within herbal medicine and some supplement research rather than an official medical or regulatory category. NCCIH does not define or use the term on its herb-specific pages, and there is no single agreed testing standard that a mushroom must pass to be labeled an adaptogen.

Can I take a mushroom supplement instead of my prescribed anxiety medication?

This is a decision to make only with the clinician who prescribed your medication. Stopping or changing a prescribed mental health treatment without medical guidance can be harmful, and no mushroom species currently has evidence strong enough to be considered a substitute for prescribed care.

Which mushroom has the most human evidence for stress specifically?

Reishi has the most direct human research among individual mushroom species, though it is still limited to a small number of studies. Multi-mushroom blends that include reishi alongside lion’s mane, cordyceps, shiitake and maitake have also been tested, but blend studies cannot isolate which mushroom, if any, is responsible for the results.

Educational disclaimer

This article is for general education only. It is not medical advice, and it does not diagnose, treat, or promise a specific outcome for any condition. It is not a recommendation to start, stop, or change any medication or supplement. Speak with a qualified healthcare provider about your individual health history, current medications, and any symptoms of stress or anxiety before making decisions about supplements.

  • About
  • Editorial Standards
  • Evidence Grading
  • Medical Disclaimer
  • Ownership & Disclosure
  • Contact
  • Privacy